Latest / Stock Movers / Kingspan Soars, Daimler Truck Slumps, Genmab Jumps
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: Let's take a look at some stocks on the move
- 0:18Speaker 1: today and you're I'm Charles's Caple with Caroline Hepka. We're
- 0:22Speaker 1: joined by Bloomberg reporter Chloe Melee. Let's start with installation
- 0:25Speaker 1: specialist Kingspan Whire Investors warming to the stock.
- 0:29Speaker 3: Yeah, Well for Kingspan, calling it an installation specialists makes
- 0:32Speaker 3: it sound a little bit more boring than it actually is,
- 0:34Speaker 3: because it does have a big exposure to data center
- 0:38Speaker 3: construction and that is what is really driving that stock
- 0:41Speaker 3: this morning. So it's doing very well in the unit
- 0:45Speaker 3: that makes that infrastructure for data centers and makes walls, ceilings,
- 0:49Speaker 3: liquid calling systems as well for that end market.
- 0:53Speaker 4: And it's a market that has been doing.
- 0:55Speaker 3: Very very well, with sales really jumping in that unit
- 0:59Speaker 3: and the backline also being very strong. It's particularly interesting
- 1:03Speaker 3: given that this is actually a unit that they had
- 1:05Speaker 3: wanted to list and it's now an IPO process that
- 1:09Speaker 3: they've completely abandoned, and you know, it's the best performing
- 1:13Speaker 3: unit by far, so I'm sure that they're glad that
- 1:15Speaker 3: they kept it. They also mentioned that they are pausing
- 1:18Speaker 3: their buyback to preserve some dry powder, and the CEO
- 1:22Speaker 3: said to analyst this morning that the company was looking
- 1:25Speaker 3: at some chunky deals, that they had a headroom of
- 1:28Speaker 3: about one billion euros and there were loads of opportunities
- 1:31Speaker 3: that would potentially fit within that scope. So this is
- 1:35Speaker 3: one of those companies that's a little bit of a
- 1:37Speaker 3: lesser known sort of AI winner, and we could probably
- 1:40Speaker 3: hear something from this company about a potential deal coming soon.
- 1:45Speaker 5: Okay, that's interesting. On Kingspan and the AI link, let's
- 1:49Speaker 5: also talk about the German manufactured Daimler truck a drop
- 1:54Speaker 5: in their shares why.
- 1:56Speaker 3: Yeah, So this is really the same kind of challenge
- 1:59Speaker 3: that i AM has been facing over the last few quarters,
- 2:02Speaker 3: which is a lot of weakness in the North American
- 2:04Speaker 3: truck market because of those tariffs, and it's something that
- 2:09Speaker 3: it has been dealing with for a while because it
- 2:11Speaker 3: makes a significant share of its trucks bound for the
- 2:15Speaker 3: US in Mexico, so it's subject to the twenty five
- 2:19Speaker 3: percent duty on those heavy truck imports that took effect
- 2:22Speaker 3: last autumn. So In response to that, it said that
- 2:25Speaker 3: it was planning on building a new manufacturing plant in
- 2:29Speaker 3: the US to reduce some of that tariff exposure. But
- 2:32Speaker 3: this probably was not enough to really reassure investors, given
- 2:35Speaker 3: that there's been also just general weakness that in that business,
- 2:40Speaker 3: both in the US business.
- 2:41Speaker 4: But outside of that as well.
- 2:43Speaker 3: The orders were quite weak, the guidance is quite soft,
- 2:47Speaker 3: and so all of that is really weighing on the
- 2:49Speaker 3: shares this morning, but the primary driver of.
- 2:51Speaker 4: That is really that weakness in North America.
- 2:54Speaker 1: Finally, solid earnings for Danish biotech company gen Mab tell
- 2:58Speaker 1: us more.
- 2:59Speaker 5: Yeah.
- 3:00Speaker 3: Gen Mab makes antibody therapeutics and so reported better than
- 3:06Speaker 3: expected revenue, better than expected profit for the second quarter,
- 3:09Speaker 3: and it also boosted.
- 3:11Speaker 4: Its outlook for the year. So the analysts have said that.
- 3:14Speaker 3: Those were very solid results, and they have a pointed
- 3:18Speaker 3: out as well that there are some readout some some
- 3:21Speaker 3: clinical trial readouts coming out later this year in the
- 3:23Speaker 3: fourth quarter of this year, which could be really big catalyst.
- 3:27Speaker 3: There's one in particular that is related to lymphoma and
- 3:31Speaker 3: that could be a six hundred million dollar commercial opportunity
- 3:35Speaker 3: in twenty thirty five.
- 3:36Speaker 4: According to Bloomberg Intelligence.
- 3:39Speaker 3: So there's a few things coming down the pipeline for
- 3:41Speaker 3: this company, and it seems that investors and analysts are
- 3:44Speaker 3: quite enthusiastic about its growth prospects.
- 3:48Speaker 2: The Stock Mover's report from Bloomberg Radio. Check back with
- 3:52Speaker 2: us throughout the day for the latest roundup of companies
- 3:55Speaker 2: making news on Wall Street and for the latest market
- 3:58Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:02Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:06Speaker 2: the Bloomberg Business app.